All In MedTech

Device Trial Radar · NCT02461576

Clinical Evaluation of the Xpert® HIV-1 VL

Clinical Evaluation of the Xpert® HIV-1 VL: A Method Comparison Study

Last checked: Nov 20, 2026Latest source record: Feb 6, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

966

Actual

Start

Jul 2015

Primary completion

Feb 24, 2017

Study completion Feb 24, 2017

Sponsor

Lead sponsor
CepheidNot on our public-company list
Sponsor type
Industry
First posted
Jun 3, 2015

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Compare the clinical performance of the Xpert® HIV-1 VL to another FDA approved HIV-1 RNA quantitative assay using frozen and fresh specimens from known HIV-1 positive individuals.

Conditions

  • Human Immunodeficiency Virus

Interventions

  • Xpert HIV-1 VL AssayDevice

    in vitro diagnostic test to quantify HIV-1 RNA

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Quantification of HIV-1 RNA in copies/mL in known HIV-1 positive subjectsTime frame: 1 day (A single time point)

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.